With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors||University of Florida / Catherine Flores, PhD||Young Investigator Grants||2015||Florida|
|Engager T Cells: A Novel Immunotherapeutic for AML||University of Michigan / Challice Bonifant, MD, PhD||Young Investigator Grants||2015||Michigan|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|Optimizing Bispecific Antibody Therapy for Acute Leukemias||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD||Innovation Grants||2015||Washington|
|Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma||Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD||Innovation Grants||2015||California|
|Single Cell Analysis of Leukemia Initiation||Stanford University / Michael Cleary, MD||Innovation Grants||2015||California|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2015||California|
|Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering||Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD||Innovation Grants||2015||New York|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|